Hydrogen Gas Slows Lung Cancer Growth by Reprogramming Immune Cells
Hydrogen suppressed tumor growth during chronic intermittent hypoxia via modulating macrophage polarization
Research hubs: Respiratory System · Cardiovascular System
- Evidence type
- Animal study (mouse)
- Authors
- Qing-Qing Liu, Chen-Bing Zhao, Zhuo Wang, Mengfang Sun, Ke-Rong Qi, Han Liu, Qian Li, Yashuo Zhao, Ya-Jing Guo, En-Sheng Ji
- Journal
- Nature Scientific Reports
- Year
- 2026
- DOI
- 10.1038/s41598-026-57825-3
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Lung Cancer
- Body System
- Respiratory
This research was done in animals. Results in animals often don't carry over to people.
TL;DR
Hydrogen suppressed lung tumor growth in intermittent hypoxia models, partly by shifting macrophages toward an M1 phenotype and inhibiting CCL2-CCR2 signaling.
Key Finding
Hydrogen gas suppressed tumor growth in mice with chronic intermittent hypoxia by shifting immune cells toward a cancer-fighting state and blocking a key signaling pathway that promotes tumor spread.
Summary
Researchers studied whether hydrogen gas could help slow lung cancer growth in mice, especially those with a condition that mimics sleep apnea (repeated drops in oxygen). They found that hydrogen treatment reduced tumor growth by changing how immune cells (called macrophages) behaved around the tumors and by blocking a chemical pathway that helps tumors spread. Hydrogen also directly slowed the growth and movement of cancer cells in laboratory tests.
Practical Takeaway
This is early-stage research conducted only in mice, not humans. While the results are promising for potential future cancer therapies, it is far too soon to draw conclusions about hydrogen's effectiveness for lung cancer in people. Much more research, including human clinical trials, would be needed before hydrogen could be considered a legitimate cancer treatment.
Abstract (excerpt)
Lung cancer remains a major challenge in clinical treatment, as current therapeutic strategies often fail to effectively halt disease progression. Chronic intermittent hypoxia (CIH), a hallmark pathological feature of obstructive sleep apnea (OSA), has been implicated in promoting tumor invasion…